Apontis Pharma AG (APPH) — Financial Flexibility Index
Apontis Pharma AG (APPH) has a Financial Flexibility Index of -0.16x as of June 2025. Free cash flow of €-1.94 Million (operating CF €-1.94 Million minus capex €1.54K) represents 0% of total liabilities (€12.37 Million). Check APPH PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Apontis Pharma AG Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Apontis Pharma AG across 6 annual periods. See APPH current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Apontis Pharma AG (2019–2024)
Year-by-year free cash flow to debt coverage for Apontis Pharma AG. For the full company profile including market capitalisation, see Apontis Pharma AG stock valuation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.04x | €-560.40K | €-2.90 Million | €13.36 Million | ▲ +87.8% |
| 2023 | -0.34x | €-9.34 Million | €-12.60 Million | €27.20 Million | ▼ -143.9% |
| 2022 | 0.78x | €14.30 Million | €11.02 Million | €18.29 Million | ▲ +106.0% |
| 2021 | 0.38x | €5.09 Million | €3.43 Million | €13.42 Million | ▲ +356.6% |
| 2020 | 0.08x | €2.18 Million | €1.45 Million | €26.23 Million | ▲ +165.5% |
| 2019 | 0.03x | €812.35K | €-238.07K | €25.94 Million | — |